MARCIA MIELKE: Open Payments
NPI 1114953973 · LAKEWOOD, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$849 in 27 payments from 12 companies in 2025. Trend: 2023 $62 · 2024 $311 · 2025 $849
Food & beverage: $849
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $325 |
| Axsome Therapeutics, Inc. | 3 | $99 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $69 |
| Collegium Pharmaceutical, Inc. | 3 | $59 |
| Galderma Laboratories, L.P. | 1 | $56 |
| Neurocrine BioSciences, Inc. | 2 | $52 |
| Otsuka America Pharmaceutical, Inc. | 2 | $44 |
| Alkermes, Inc. | 2 | $42 |
| Corium, LLC | 2 | $40 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
Products named: BOTOX, Auvelity, CAPLYTA, Jornay PM, DYSPORT, VRAYLAR, INGREZZA, REXULTI.
Industry payments across CO — which companies pay providers there.
